Abstract
BACKGROUND Brain metastasis has been reported in 25-40 % of cancers and is associated with fairly dismal outcome with a mean survival period of 6-9 months as reported in various case series. In management of brain metastasis, there is extensive published experience of Stereotactic Radiosurgery (SRS)/ Fractionated Stereotactic Radiosurgery (FSR) with control rates equal to or higher than those for surgery for single/oligo metastasis. The term FSR refers to stereotactically guided delivery of highly conformal radiation to a defined target volume in multiple fractions (4-5), typically using non-invasive positioning.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
